TrademarkDir
AMBRILIA BIOPHARMA
DEAD

Serial Number

78769678

Owner

AMBRILIA BIOPHARMA INC.

Attorney

David A. Weinstein

Filing Date

Dec 8, 2005

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

AMBRILIA BIOPHARMA Trademark

Serial Number: 78769678

AMBRILIA BIOPHARMA is a trademark filed by AMBRILIA BIOPHARMA INC. on December 8, 2005. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AMBRILIA BIOPHARMA INC. (5 trademarks)

1000 CHEMIN DU GOLF
VERDUN, QUEBEC PROVINCE H3E 1H4 , CA

Entity Type: 03

PROCYON BIOPHARMA INC. (5 trademarks)

1000 Chemin du Golf
Verdun, Quebec Prov. H3E 1H4 , CA

Entity Type: 03

Trademark Details

Filing Date

December 8, 2005

Registration Date

Not Registered

Goods & Services

Manufacturing services for others in the field of therapeutic and diagnostic products

Pharmaceutical preparations for the treatment of cancer and infectious diseases

Pharmaceutical research and development in the field of therapeutic and diagnostic products

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 4, 2011 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 4, 2011 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 19, 2010 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 19, 2010 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 19, 2010 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 18, 2010 RCCK
ASSIGNED TO LIE
Aug 18, 2010 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 16, 2010 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 16, 2010 GNSL
SUSPENSION LETTER WRITTEN
Feb 16, 2010 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 2, 2010 CRFA
ASSIGNED TO LIE
Jan 29, 2010 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 27, 2010 TCCA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 27, 2010 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 29, 2009 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 29, 2009 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 29, 2009 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 27, 2009 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 27, 2009 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 27, 2009 GNSL
SUSPENSION LETTER WRITTEN
Jan 27, 2009 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2009 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 13, 2009 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 18, 2008 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 18, 2008 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 18, 2008 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 17, 2008 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 17, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 17, 2008 GNSL
SUSPENSION LETTER WRITTEN
Jan 17, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2008 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 8, 2008 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 30, 2007 TCCA
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 24, 2007 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 24, 2007 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 24, 2007 CNSI
ASSIGNED TO LIE
Jul 16, 2007 ALIE
LETTER OF SUSPENSION E-MAILED
Jan 16, 2007 GNSL
SUSPENSION LETTER WRITTEN
Jan 16, 2007 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 4, 2007 TEME
ASSIGNED TO LIE
Jan 4, 2007 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2006 TROA
NON-FINAL ACTION E-MAILED
Jun 1, 2006 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2006 CNRT
ASSIGNED TO EXAMINER
May 27, 2006 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 12, 2006 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 7, 2006 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 7, 2006 COAR
NEW APPLICATION ENTERED
Dec 13, 2005 NWAP

Related Trademarks

More from this Owner

AMBRILIA BIOPHARMA logo

AMBRILIA BIOPHARMA

STELLIUS BIOPHARMA

STELLIUS BIOPHARMA

STELLIUS BIOPHARMA

STELLIUS BIOPHARMA

FIBROSTAT

FIBROSTAT

FIBROSTAT

FIBROSTAT

FIBROSTAT

FIBROSTAT